Adults and adolescents (12 years and older) with chronic spontaneous urticaria who still have symptoms after treatment with H1 antihistamines.

Patients with recurrent or metastatic cervical cancer who have PD-L1-positive expression (CPS≥1) and have previously failed platinum-containing chemotherapy.

This product is intended for the prevention of diseases (COVID-19) caused by infection with the novel coronavirus (SARS-CoV-2).

COVID-19 mRNA Vaccine(containing BA.5 key mutations)